Loading...
Publication
Vacinas para Coronavírus (COVID-19; SARS- COV-2): mapeamento preliminar de artigos, patentes, testes clínicos e mercado
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 456 KB | Adobe PDF |
Advisor(s)
Abstract(s)
O recente surto de Coronavírus gerou uma pandemia mundial. Este artigo consiste em um estudo exploratório para avaliar parcialmente o volume existente de material e o potencial de aprofundar futuras prospecções tecnológicas. O propósito deste estudo é o de pré-avaliar o conhecimento que existe em ciência (por meio de artigos), em tecnologia (por meio de patentes) e em testes clínicos e prontos para uso (por meio de vacinas disponíveis no mercado). Os artigos foram mapeados na Web of Knowledge, o mapeamento patentário usou a base Worldwide europeia, usando o software Orbit®. Os estudos clínicos utilizaram a base de dados dos Estados Unidos da América (EUA). Foram encontradas 991 patentes, 125 artigos e 115 estudos clínicos sendo apenas dois que se referem explicitamente a vacinas. A evolução anual mostra um crescimento exponencial a partir de 2002-2004 para artigos e para patentes. A grande maioria dos estudos clínicos nem foi ainda iniciada (apenas 15% foram completados), evidenciando que há necessidade urgente de estimular sua maturação. Não existe, no momento, no mercado, uma vacina que seja considerada efetiva mundialmente.
The recent Coronavirus outbreak has sparked a worldwide pandemic. This article consists of an exploratory study to assess the existing volume of material and the potential for further technological assessment and forecast. It is used to assess the knowledge that exists in science (through articles), in technology (through patents), in clinical tests and ready for use (through vaccines available on the market). The articles were mapped on the Web of Knowledge, the patent assessment used the European Worldwide database, using the Orbit® software. 991 patents, 125 articles and 115 clinical studies were found, with only 2 explicitly referring to vaccines. The annual evolution shows an exponential growth from 2002-2004 for articles and for patents. The vast majority of clinical studies have not yet started (only 15% have been completed), showing that there is an urgent need to stimulate their maturation. There is still no vaccine on the market that is considered worldwide effective.
The recent Coronavirus outbreak has sparked a worldwide pandemic. This article consists of an exploratory study to assess the existing volume of material and the potential for further technological assessment and forecast. It is used to assess the knowledge that exists in science (through articles), in technology (through patents), in clinical tests and ready for use (through vaccines available on the market). The articles were mapped on the Web of Knowledge, the patent assessment used the European Worldwide database, using the Orbit® software. 991 patents, 125 articles and 115 clinical studies were found, with only 2 explicitly referring to vaccines. The annual evolution shows an exponential growth from 2002-2004 for articles and for patents. The vast majority of clinical studies have not yet started (only 15% have been completed), showing that there is an urgent need to stimulate their maturation. There is still no vaccine on the market that is considered worldwide effective.
Description
Keywords
Pandemia Imunização Micro-organismos Biotecnologia Avaliação Tecnológica Conhecimento Científico COVID-19 Vacina Coronavírus Pandemic Immunization Microorganisms Technological Evaluation Biotechnology Scientific Knowledge Vaccine
Citation
Quintella, C. Mata, A. M., Ghesti, G. & Mata, P. (2020). Vacinas para Coronavírus (COVID-19; SARS- COV-2): mapeamento preliminar de artigos, patentes, testes clínicos e mercado. Cadernos de Prospecção – Salvador, 13 (1), p. 3-12